Exscientia plc: Exscientia Announces Collaboration with Charité to Advance Development of Precision Medicine Platform
Partnership will further validate Exscientia's functional drug testing platform to predict response in haematological cancers - Exscientia plc (Nasdaq: EXAI) today announced a new collaboration with
Source: finanznachrichten.de